Cite Filings / COGT
Feed Companies Filings Check
Sign in

CIK 0001622229 · Large accelerated filer

Cogent Biosciences, Inc.

Sign in to watch
Ticker
COGT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
465308248
Phone
617-945-5576
Business address
180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
Former names
Unum Therapeutics Inc., Unum Therapeutics, Inc.
Filings Insiders Search text
All 616 Financials 136 Shareholder Meetings 14 Executive Compensation 117 Insider Trading 248 Beneficial Ownership Interest 115 Business Combinations 103 Public Offerings 46 Mutual Funds and ETFs 9 Others 63
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-23
  3. DEF 14A Proxy Proxy Statement 2025-04-22
  4. DEF 14A Proxy Proxy Statement 2024-04-23
  5. DEF 14A Proxy Proxy Statement 2023-04-25
  6. DEF 14A Proxy Proxy Statement 2022-04-26
  7. DEF 14A Proxy Proxy Statement 2021-04-30
  8. DEF 14A Proxy Proxy Statement 2020-04-29
  9. DEF 14A Proxy Proxy Statement 2020-02-18
  10. DEF 14A Proxy Proxy Statement 2019-04-30

Page 1 of 1 · 9 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…